Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Kyverna Therapeutics, Inc.

Get SEC filing alerts via email and in your feed for Kyverna Therapeutics, Inc.

KYTX

Kyverna Therapeutics, Inc.

Latest news & discussion for Kyverna Therapeutics, Inc.:

1
1
Kyverna Therapeutics, Inc. Kyverna Therapeutics Reports $127.5M Net Loss for 2024, Driven by Increased R&D Expenses

Via official filing (AI summary) | 24 days ago | 0 comments

2
1
Kyverna Therapeutics, Inc. Kyverna Therapeutics Reports Significant Financial Developments, Including Increased Cash Reserves and Operating Expenses

Via official filing (AI summary) | 5 months ago | 0 comments